Trial Profile
Safety, pharmacokinetic and pharmacodynamic study of ASP5094 in healthy subjects
Status:
Not stated
Phase of Trial:
Phase I
Latest Information Update: 31 Jan 2017
Price :
$35
*
At a glance
- Drugs ASP 5094 (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions; First in man; Pharmacodynamics; Pharmacokinetics
- 31 Jan 2017 New trial record